Monopar Therapeutics (MNPR)
(Delayed Data from NSDQ)
$0.65 USD
-0.01 (-1.53%)
Updated May 1, 2024 03:25 PM ET
After-Market: $0.66 +0.01 (1.54%) 7:58 PM ET
2-Buy of 5 2
F Value B Growth D Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/09/2024
Time: -- |
3/2024 | $-0.17 | 0.00% |
Earnings Summary
For their last quarter, Monopar Therapeutics (MNPR) reported earnings of -$0.12 per share, beating the Zacks Consensus Estimate of $-0.17 per share. This reflects a positive earnings surprise of 29.41%. Look out for MNPR's next earnings release expected on May 09, 2024. For the next earning release, we expect the company to report earnings of -$0.17 per share, reflecting a year-over-year increase of 10.53%.
Earnings History
Price & Consensus
Zacks News for MNPR
All You Need to Know About Monopar Therapeutics (MNPR) Rating Upgrade to Buy
MNPR: What are Zacks experts saying now?
Zacks Private Portfolio Services